
Global Gamma-Aminobutyric Acid (GABA) Supplement Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Gamma-Aminobutyric Acid (GABA) Supplement market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Gamma-Aminobutyric Acid (GABA) Supplement is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Gamma-Aminobutyric Acid (GABA) Supplement is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Gamma-Aminobutyric Acid (GABA) Supplement market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Gamma-Aminobutyric Acid (GABA) Supplement is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Gamma-Aminobutyric Acid (GABA) Supplement market include Amazing Nutrition, Country Life, Horbaach, Integrative Therapeutics, Nature's Truth, Now Foods, Nusa Pure, Nutrabio and Nutrabulk, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Gamma-Aminobutyric Acid (GABA) Supplement, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Gamma-Aminobutyric Acid (GABA) Supplement, also provides the sales of main regions and countries. Of the upcoming market potential for Gamma-Aminobutyric Acid (GABA) Supplement, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gamma-Aminobutyric Acid (GABA) Supplement sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Gamma-Aminobutyric Acid (GABA) Supplement market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Gamma-Aminobutyric Acid (GABA) Supplement sales, projected growth trends, production technology, application and end-user industry.
Gamma-Aminobutyric Acid (GABA) Supplement Segment by Company
Amazing Nutrition
Country Life
Horbaach
Integrative Therapeutics
Nature's Truth
Now Foods
Nusa Pure
Nutrabio
Nutrabulk
Pure Encapsulations
Solgar
Thorne
Vitanica
Gamma-Aminobutyric Acid (GABA) Supplement Segment by Type
Capsules
Powder
Gamma-Aminobutyric Acid (GABA) Supplement Segment by Application
Retailer
Online Shopping
Others
Gamma-Aminobutyric Acid (GABA) Supplement Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Gamma-Aminobutyric Acid (GABA) Supplement status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Gamma-Aminobutyric Acid (GABA) Supplement market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gamma-Aminobutyric Acid (GABA) Supplement significant trends, drivers, influence factors in global and regions.
6. To analyze Gamma-Aminobutyric Acid (GABA) Supplement competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gamma-Aminobutyric Acid (GABA) Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gamma-Aminobutyric Acid (GABA) Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gamma-Aminobutyric Acid (GABA) Supplement.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Gamma-Aminobutyric Acid (GABA) Supplement market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gamma-Aminobutyric Acid (GABA) Supplement industry.
Chapter 3: Detailed analysis of Gamma-Aminobutyric Acid (GABA) Supplement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Gamma-Aminobutyric Acid (GABA) Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Gamma-Aminobutyric Acid (GABA) Supplement in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
According to APO Research, the global Gamma-Aminobutyric Acid (GABA) Supplement market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Gamma-Aminobutyric Acid (GABA) Supplement is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Gamma-Aminobutyric Acid (GABA) Supplement is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Gamma-Aminobutyric Acid (GABA) Supplement market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Gamma-Aminobutyric Acid (GABA) Supplement is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Gamma-Aminobutyric Acid (GABA) Supplement market include Amazing Nutrition, Country Life, Horbaach, Integrative Therapeutics, Nature's Truth, Now Foods, Nusa Pure, Nutrabio and Nutrabulk, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Gamma-Aminobutyric Acid (GABA) Supplement, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Gamma-Aminobutyric Acid (GABA) Supplement, also provides the sales of main regions and countries. Of the upcoming market potential for Gamma-Aminobutyric Acid (GABA) Supplement, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gamma-Aminobutyric Acid (GABA) Supplement sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Gamma-Aminobutyric Acid (GABA) Supplement market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Gamma-Aminobutyric Acid (GABA) Supplement sales, projected growth trends, production technology, application and end-user industry.
Gamma-Aminobutyric Acid (GABA) Supplement Segment by Company
Amazing Nutrition
Country Life
Horbaach
Integrative Therapeutics
Nature's Truth
Now Foods
Nusa Pure
Nutrabio
Nutrabulk
Pure Encapsulations
Solgar
Thorne
Vitanica
Gamma-Aminobutyric Acid (GABA) Supplement Segment by Type
Capsules
Powder
Gamma-Aminobutyric Acid (GABA) Supplement Segment by Application
Retailer
Online Shopping
Others
Gamma-Aminobutyric Acid (GABA) Supplement Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Gamma-Aminobutyric Acid (GABA) Supplement status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Gamma-Aminobutyric Acid (GABA) Supplement market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gamma-Aminobutyric Acid (GABA) Supplement significant trends, drivers, influence factors in global and regions.
6. To analyze Gamma-Aminobutyric Acid (GABA) Supplement competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gamma-Aminobutyric Acid (GABA) Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gamma-Aminobutyric Acid (GABA) Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gamma-Aminobutyric Acid (GABA) Supplement.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Gamma-Aminobutyric Acid (GABA) Supplement market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gamma-Aminobutyric Acid (GABA) Supplement industry.
Chapter 3: Detailed analysis of Gamma-Aminobutyric Acid (GABA) Supplement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Gamma-Aminobutyric Acid (GABA) Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Gamma-Aminobutyric Acid (GABA) Supplement in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Table of Contents
190 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2020-2031)
- 1.2.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume (2020-2031)
- 1.2.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Average Price (2020-2031)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Gamma-Aminobutyric Acid (GABA) Supplement Market Dynamics
- 2.1 Gamma-Aminobutyric Acid (GABA) Supplement Industry Trends
- 2.2 Gamma-Aminobutyric Acid (GABA) Supplement Industry Drivers
- 2.3 Gamma-Aminobutyric Acid (GABA) Supplement Industry Opportunities and Challenges
- 2.4 Gamma-Aminobutyric Acid (GABA) Supplement Industry Restraints
- 3 Gamma-Aminobutyric Acid (GABA) Supplement Market by Company
- 3.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Company Revenue Ranking in 2024
- 3.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Revenue by Company (2020-2025)
- 3.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Company (2020-2025)
- 3.4 Global Gamma-Aminobutyric Acid (GABA) Supplement Average Price by Company (2020-2025)
- 3.5 Global Gamma-Aminobutyric Acid (GABA) Supplement Company Ranking (2023-2025)
- 3.6 Global Gamma-Aminobutyric Acid (GABA) Supplement Company Manufacturing Base and Headquarters
- 3.7 Global Gamma-Aminobutyric Acid (GABA) Supplement Company Product Type and Application
- 3.8 Global Gamma-Aminobutyric Acid (GABA) Supplement Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.9.3 2024 Gamma-Aminobutyric Acid (GABA) Supplement Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
- 4 Gamma-Aminobutyric Acid (GABA) Supplement Market by Type
- 4.1 Gamma-Aminobutyric Acid (GABA) Supplement Type Introduction
- 4.1.1 Capsules
- 4.1.2 Powder
- 4.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Type
- 4.2.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Type (2020-2031)
- 4.2.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume Share by Type (2020-2031)
- 4.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Type
- 4.3.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Type (2020-2031)
- 4.3.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type (2020-2031)
- 5 Gamma-Aminobutyric Acid (GABA) Supplement Market by Application
- 5.1 Gamma-Aminobutyric Acid (GABA) Supplement Application Introduction
- 5.1.1 Retailer
- 5.1.2 Online Shopping
- 5.1.3 Others
- 5.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Application
- 5.2.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume by Application (2020-2031)
- 5.2.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Volume Share by Application (2020-2031)
- 5.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Application
- 5.3.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Application (2020-2031)
- 5.3.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application (2020-2031)
- 6 Gamma-Aminobutyric Acid (GABA) Supplement Regional Sales and Value Analysis
- 6.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Region (2020-2031)
- 6.2.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Region: 2020-2025
- 6.2.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Region (2026-2031)
- 6.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Region: 2020 VS 2024 VS 2031
- 6.4 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Region (2020-2031)
- 6.4.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Region: 2020-2025
- 6.4.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Region (2026-2031)
- 6.5 Global Gamma-Aminobutyric Acid (GABA) Supplement Market Price Analysis by Region (2020-2025)
- 6.6 North America
- 6.6.1 North America Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2020-2031)
- 6.6.2 North America Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country, 2024 VS 2031
- 6.7 Europe
- 6.7.1 Europe Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2020-2031)
- 6.7.2 Europe Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country, 2024 VS 2031
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2020-2031)
- 6.8.2 Asia-Pacific Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country, 2024 VS 2031
- 6.9 South America
- 6.9.1 South America Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2020-2031)
- 6.9.2 South America Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country, 2024 VS 2031
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Gamma-Aminobutyric Acid (GABA) Supplement Sales Value (2020-2031)
- 6.10.2 Middle East & Africa Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Country, 2024 VS 2031
- 7 Gamma-Aminobutyric Acid (GABA) Supplement Country-level Sales and Value Analysis
- 7.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Country: 2020 VS 2024 VS 2031
- 7.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Country: 2020 VS 2024 VS 2031
- 7.3 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Country (2020-2031)
- 7.3.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Country (2020-2025)
- 7.3.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales by Country (2026-2031)
- 7.4 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Country (2020-2031)
- 7.4.1 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Country (2020-2025)
- 7.4.2 Global Gamma-Aminobutyric Acid (GABA) Supplement Sales Value by Country (2026-2031)
- 7.5 USA
- 7.5.1 USA Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.5.2 USA Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.5.3 USA Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.6 Canada
- 7.6.1 Canada Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.6.2 Canada Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Canada Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.7 Mexico
- 7.6.1 Mexico Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.6.2 Mexico Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Mexico Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.8 Germany
- 7.8.1 Germany Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.8.2 Germany Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.8.3 Germany Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.9 France
- 7.9.1 France Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.9.2 France Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.9.3 France Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.10 U.K.
- 7.10.1 U.K. Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.10.2 U.K. Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.10.3 U.K. Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.11 Italy
- 7.11.1 Italy Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.11.2 Italy Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Italy Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.12 Spain
- 7.12.1 Spain Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.12.2 Spain Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Spain Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.13 Russia
- 7.13.1 Russia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.13.2 Russia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Russia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.14 Netherlands
- 7.14.1 Netherlands Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.14.2 Netherlands Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.14.3 Netherlands Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.15.2 Nordic Countries Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Nordic Countries Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.16 China
- 7.16.1 China Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.16.2 China Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.16.3 China Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.17 Japan
- 7.17.1 Japan Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.17.2 Japan Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.17.3 Japan Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.18 South Korea
- 7.18.1 South Korea Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.18.2 South Korea Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.18.3 South Korea Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.19 India
- 7.19.1 India Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.19.2 India Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.19.3 India Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.20 Australia
- 7.20.1 Australia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.20.2 Australia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Australia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.21.2 Southeast Asia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Southeast Asia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.22 Brazil
- 7.22.1 Brazil Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.22.2 Brazil Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Brazil Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.23 Argentina
- 7.23.1 Argentina Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.23.2 Argentina Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Argentina Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.24 Chile
- 7.24.1 Chile Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.24.2 Chile Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Chile Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.25 Colombia
- 7.25.1 Colombia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.25.2 Colombia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Colombia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.26 Peru
- 7.26.1 Peru Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.26.2 Peru Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Peru Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.27.2 Saudi Arabia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.27.3 Saudi Arabia Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.28 Israel
- 7.28.1 Israel Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.28.2 Israel Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Israel Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.29 UAE
- 7.29.1 UAE Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.29.2 UAE Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.29.3 UAE Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.30 Turkey
- 7.30.1 Turkey Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.30.2 Turkey Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Turkey Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.31 Iran
- 7.31.1 Iran Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.31.2 Iran Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.31.3 Iran Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 7.32 Egypt
- 7.32.1 Egypt Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Growth Rate (2020-2031)
- 7.32.2 Egypt Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Type, 2024 VS 2031
- 7.32.3 Egypt Gamma-Aminobutyric Acid (GABA) Supplement Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Amazing Nutrition
- 8.1.1 Amazing Nutrition Comapny Information
- 8.1.2 Amazing Nutrition Business Overview
- 8.1.3 Amazing Nutrition Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2020-2025)
- 8.1.4 Amazing Nutrition Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
- 8.1.5 Amazing Nutrition Recent Developments
- 8.2 Country Life
- 8.2.1 Country Life Comapny Information
- 8.2.2 Country Life Business Overview
- 8.2.3 Country Life Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2020-2025)
- 8.2.4 Country Life Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
- 8.2.5 Country Life Recent Developments
- 8.3 Horbaach
- 8.3.1 Horbaach Comapny Information
- 8.3.2 Horbaach Business Overview
- 8.3.3 Horbaach Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2020-2025)
- 8.3.4 Horbaach Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
- 8.3.5 Horbaach Recent Developments
- 8.4 Integrative Therapeutics
- 8.4.1 Integrative Therapeutics Comapny Information
- 8.4.2 Integrative Therapeutics Business Overview
- 8.4.3 Integrative Therapeutics Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2020-2025)
- 8.4.4 Integrative Therapeutics Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
- 8.4.5 Integrative Therapeutics Recent Developments
- 8.5 Nature's Truth
- 8.5.1 Nature's Truth Comapny Information
- 8.5.2 Nature's Truth Business Overview
- 8.5.3 Nature's Truth Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2020-2025)
- 8.5.4 Nature's Truth Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
- 8.5.5 Nature's Truth Recent Developments
- 8.6 Now Foods
- 8.6.1 Now Foods Comapny Information
- 8.6.2 Now Foods Business Overview
- 8.6.3 Now Foods Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2020-2025)
- 8.6.4 Now Foods Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
- 8.6.5 Now Foods Recent Developments
- 8.7 Nusa Pure
- 8.7.1 Nusa Pure Comapny Information
- 8.7.2 Nusa Pure Business Overview
- 8.7.3 Nusa Pure Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2020-2025)
- 8.7.4 Nusa Pure Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
- 8.7.5 Nusa Pure Recent Developments
- 8.8 Nutrabio
- 8.8.1 Nutrabio Comapny Information
- 8.8.2 Nutrabio Business Overview
- 8.8.3 Nutrabio Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2020-2025)
- 8.8.4 Nutrabio Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
- 8.8.5 Nutrabio Recent Developments
- 8.9 Nutrabulk
- 8.9.1 Nutrabulk Comapny Information
- 8.9.2 Nutrabulk Business Overview
- 8.9.3 Nutrabulk Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2020-2025)
- 8.9.4 Nutrabulk Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
- 8.9.5 Nutrabulk Recent Developments
- 8.10 Pure Encapsulations
- 8.10.1 Pure Encapsulations Comapny Information
- 8.10.2 Pure Encapsulations Business Overview
- 8.10.3 Pure Encapsulations Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2020-2025)
- 8.10.4 Pure Encapsulations Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
- 8.10.5 Pure Encapsulations Recent Developments
- 8.11 Solgar
- 8.11.1 Solgar Comapny Information
- 8.11.2 Solgar Business Overview
- 8.11.3 Solgar Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2020-2025)
- 8.11.4 Solgar Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
- 8.11.5 Solgar Recent Developments
- 8.12 Thorne
- 8.12.1 Thorne Comapny Information
- 8.12.2 Thorne Business Overview
- 8.12.3 Thorne Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2020-2025)
- 8.12.4 Thorne Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
- 8.12.5 Thorne Recent Developments
- 8.13 Vitanica
- 8.13.1 Vitanica Comapny Information
- 8.13.2 Vitanica Business Overview
- 8.13.3 Vitanica Gamma-Aminobutyric Acid (GABA) Supplement Sales, Value and Gross Margin (2020-2025)
- 8.13.4 Vitanica Gamma-Aminobutyric Acid (GABA) Supplement Product Portfolio
- 8.13.5 Vitanica Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Gamma-Aminobutyric Acid (GABA) Supplement Value Chain Analysis
- 9.1.1 Gamma-Aminobutyric Acid (GABA) Supplement Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Gamma-Aminobutyric Acid (GABA) Supplement Sales Mode & Process
- 9.2 Gamma-Aminobutyric Acid (GABA) Supplement Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Gamma-Aminobutyric Acid (GABA) Supplement Distributors
- 9.2.3 Gamma-Aminobutyric Acid (GABA) Supplement Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.